TG Therapeutics to Discuss Q1 2024 Financials and Business Update

28 June 2024

TG Therapeutics, Inc. (NASDAQ: TGTX) has announced that it will hold a conference call tomorrow, Wednesday, May 1, 2024, at 8:30 AM ET to discuss its financial results for the first quarter of 2024 and provide an outlook for the rest of the year. Michael S. Weiss, the company's Chairman and CEO, will lead the call. 

To join the conference call, participants can dial 1-877-407-8029 within the U.S. or 1-201-689-8029 from outside the U.S. using the conference title "TG Therapeutics First Quarter Update Call." A live webcast will also be available on the Events page within the Investors & Media section of the company's website at www.tgtherapeutics.com. Furthermore, an audio recording of the call will be accessible for replay on the same website for 30 days following the call.

TG Therapeutics is set to release its financial results for the first quarter in a press release before the conference call.

TG Therapeutics is a biopharmaceutical company that is fully integrated and operating on a commercial stage. The company focuses on acquiring, developing, and commercializing innovative treatments for B-cell diseases. Among its research pipeline, which includes several investigational drugs, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy). BRIUMVI is approved for treating adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. The European Commission (EC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have also approved BRIUMVI for treating adult patients with relapsing multiple sclerosis (RMS) who have active disease defined by clinical or imaging features in Europe and the United Kingdom, respectively.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!